Infinitopes
Latest round
- Seed
Last raised
- Jan 2026
Total raised
- $32M
Investors
- 12
About Infinitopes
Established in 2021 and based in Oxford, UK, Infinitopes Limited operates as a manufacturer of cancer-related vaccines. The product has been created by the business utilizing the Precision ImmunomicsTM pipeline, which identifies highly expressed and immunogenic tumor antigens by combining state-of-the-art laboratory techniques, computational analysis, and machine learning. Comparing this platform to known antigens in preclinical models, it has shown efficacy, suggesting revolutionary breakthroughs in the development of cancer vaccines.
Who invested in Infinitopes
12 investors across 3 rounds
See all investors in Infinitopes
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Infinitopes
Who invested in Infinitopes?
Infinitopes has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Infinitopes raised?
Infinitopes has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Infinitopes last raise money?
Infinitopes's most recent round on record is a Seed, in Jan 2026.
What does Infinitopes do?
Established in 2021 and based in Oxford, UK, Infinitopes Limited operates as a manufacturer of cancer-related vaccines.
Where is Infinitopes headquartered?
Infinitopes is headquartered in Oxford, UK.
Which VCs invest in companies like Infinitopes?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Infinitopes's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Infinitopes? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.